![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1422, 2012-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
European pharma face pharmacovigilance fees
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 664, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Stakeholders say EMA's proposed pharmacovigilance fees are too high
Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharma growth dominated by European firms
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 431, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
European Medicines Agency provides weekly pandemic pharmacovigilance update
Reactions Weekly, Vol. 1, Iss. 1282, 2009-01 ,pp. :